-
Medical journals
- Career
Budenofalk 2 mg rectal foam represents a major new option in the treatment of patients with ulcerous colitis
Authors: M. Lukáš
Authors‘ workplace: Klinické a výzkumné centrum pro střevní záněty, ISCARE a 1. LF UK v Praze a Ústav klinické biochemie a laboratorní diagnostiky, 1. LF UK v Praze
Published in: Gastroent Hepatol 2012; 66(5): 413-414
Category: Drug Profile
Sources
1. Brunner M, Vogelsang H, Greinwald R et al. Colonic spread and pharmacokinetics of budesonid foam in patients with mild to moderately active ulcerative colitis. Aliment Pharmacol Ther 2005; 22(5): 463–470.
2. Gross V, Ben-Meir S, Lavy A et al. Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis. Aliment Pharmacol Ther 2006; 23(2): 303–312.
3. Travis SPL, Stange EF, Lémann M et al. European evidence-based Consensus on the management of ulcerative colitis: Current management. JCC 2008; 2(1): 24–62.
Labels
Paediatric gastroenterology Gastroenterology and hepatology Surgery
Article was published inGastroenterology and Hepatology
2012 Issue 5-
All articles in this issue
- Gastrointestinal oncology – near future reality?
- Epidemiology of malignant tumours of the gastrointestinal tract in the Czech Republic – state of the art and prediction
- Reflection on the financial aspects of caring for patients with colorectal carcinoma
- National Colorectal Cancer Screening Program in the Czech Republic – past, presence and future
- Pancreatic cancer
- Endoscopic ablative therapy of the proctosigmoideal neoplastic lesions – a pilot study
- Oesophageal cancer and risk factors by histological type
- Diagnosis and therapy of celiac disease: today and tomorrow
- Non-alcoholic steatohepatitis (NASH) – every physician's concern
- Endoscopy in patients with anticoagulant and antiplatelet therapy
- Guidelines for the administration of aminosalicylatesin patients with inflammatory bowel diseases
- How to improve colorectal cancer screening?
- XXI. Spring Meeting in Loket – advances in the treatment of patients with carcinoma of the pancreas
- Prague Hepatology Meeting 2012
- Prof. MUDr. Aleš Hep, CSc., turned 60
- Budenofalk 2 mg rectal foam represents a major new option in the treatment of patients with ulcerous colitis
- Gastroenterology and Hepatology
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue- Budenofalk 2 mg rectal foam represents a major new option in the treatment of patients with ulcerous colitis
- Epidemiology of malignant tumours of the gastrointestinal tract in the Czech Republic – state of the art and prediction
- Pancreatic cancer
- Prof. MUDr. Aleš Hep, CSc., turned 60
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career